SpringerLink
Log in

EBV and B Cell Lymphomas

  • Chapter
Herpesviruses and Immunity

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

  • 126 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Thailand)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 117.69
Price includes VAT (Thailand)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 149.99
Price excludes VAT (Thailand)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 149.99
Price excludes VAT (Thailand)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunsmann, G., and Hinuma, Y., 1985, Human adult T-cell leukemia virus and its association with disease, Adv. Viral Oncol. 5:147.

    Google Scholar 

  2. Miller, G., 1980, Biology of Epstein-Barrvirus, in Viral Oncology, (G. Klein, ed.), Raven Press, New York, pp.713–738.

    Google Scholar 

  3. Klein, G., Svedmyr, E., Jondal, M., and Persson, P. O., 1976, EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients, Int.ℑ. Cancer 17:21–26.

    CAS  Google Scholar 

  4. Chen, F., Zou, J. Z., di Renzo, L., Winberg, G., Hu, L. F., Klein, E., Klein, G., and Ernberg, I., 1995, A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1, ℑ. Virol 69:3752–3758.

    CAS  Google Scholar 

  5. Lewin, N., Aman, P., Masucci, M. G., Klein, E., Klein, G., Oberg, B., Strander, H., Henle, W., and Henle, G., 1987, Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth, Int. J Cancer 39:47–476.

    Google Scholar 

  6. Klein, G., 1994, Epstein-Barrvirus strategy in normal and neoplastic B cells [Review], Cell 77:791–793.

    Article  PubMed  CAS  Google Scholar 

  7. Masucci, M. G., Ernberg, I., 1994, Epstein-Barrvirus: Adaptation to a life within the immune system Review], TrendsMicrobiol. 2:125–130.

    CAS  Google Scholar 

  8. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., and Masucci, M. G., 1995, Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1, Nature 375:685–688.

    Article  PubMed  CAS  Google Scholar 

  9. Marin, D. R., Marlowe, R. L., and Ahearn, J. M., 1994, Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells, ℑ. Virol 68:4716–4726.

    Google Scholar 

  10. Kondo, N., Inoue, R., and Orii, T., 1992, Various responses of lymphocytes to Epstein-Barr virus in patients with common variable immunodeficiency, J Clin. Lab. Immunol. 37:183–189.

    PubMed  CAS  Google Scholar 

  11. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A., 1991, Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death, Cell 65:1107–1115.

    Article  PubMed  CAS  Google Scholar 

  12. Gordon, J., and Cairns, J. A., 1991, Autocrine regulation of normal and malignant B lymphocytes [Review], Adv. Cancer Res. 56:313–334.

    PubMed  CAS  Google Scholar 

  13. Decker, L. L., Klaman, L. D., and Thorley-Lawson, D. A., 1996, Detection of the latent form of Epstein-Barrvirus DNA in the peripheral blood of healthy individuals, J Virol. 70:3286–3289.

    PubMed  CAS  Google Scholar 

  14. Henle, G., and Henle, W., 1979, The virus as the etiologic agent ofinfectious mononucleosis, in The Epstein-Barr Virus (M. Epstein, and B. Achong, eds.) Springer-Verlag, Berlin, pp, 297–320.

    Google Scholar 

  15. Svedmyr, E., Ernberg, I., Seeley, J., Weiland, O., Masucci, G., Tskuda, K., Szigeti, R., Masucci, M. G., Blomgren, H., Berthold, W., Henle, W., and Klein, G., 1984, Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectiousmononucleosis, Clin.Immunol.Immunopathol. 30:437–450.

    Article  PubMed  CAS  Google Scholar 

  16. Penn, I., 1987, Cancers following cyclosporine therapy, Transplantation 43:32–35.

    PubMed  CAS  Google Scholar 

  17. Rickinson, A. B., Murray, R. J., Brooks, J., Griffin, H., Moss, D. J., and Masucci, M. G., 1992, T cell recognition of Epstein-Barrvirus associated lymphomas [Review], Cancer Surv. 13:53–80.

    PubMed  CAS  Google Scholar 

  18. Cleary, M. L., and Sklar, J., 1984, Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas, Lancet 2:489–493.

    PubMed  CAS  Google Scholar 

  19. Kaplan, M. A., Ferry, J. A., Harris, N. L., and Jacobson, J. O., 1994, Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers, Am.J Clin. Pathol. 101:590–596.

    PubMed  CAS  Google Scholar 

  20. Gratama, J. W., Zutter, M. M., Minarovits, J., Oosterveer, M. A., Thomas, E. D., Klein, G., and Ernberg, I., 1991, Expression of Epstein-Barrvirus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients, Int. J Cancer

    Google Scholar 

  21. Young, L., Alfieri, C., Hennessy, K., Evans, H., O’Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., et al., 1989, Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease, N. Engl.ℑ. Med. 321:1080–1085.

    CAS  Google Scholar 

  22. Gaidano, G., and Dalla-Favera, R., 1995, Molecular pathogenesis of AIDS-related lymphomas, Adv. Cancer Res. 67:113–153.

    PubMed  CAS  Google Scholar 

  23. Nalesnik, M. A., Jaffe, R., Starzl, T. E., Demetris, A.J., Porter, K., Bumham, J. A., Makowa, L., Ho, M., and Locker, J., 1988, The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression, Am.ℑ. Pathol. 133:173–192.

    CAS  Google Scholar 

  24. Ho, M., Jaffe, R., Miller, G., Breinig, M. K., Dummer, J. S., Makoeka, L., Atchison, R. W., Karrer, F., Nalesnik, M. A., and Starzl, T. E., 1988, The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children, Transplantation 45:719–727.

    PubMed  CAS  Google Scholar 

  25. Shearer, W. T., Ritz, J., Finegold, M. J., Guerra, I. C., Rosenblatt, H. M., Lewis, D. E., Pollack, M. S., Taber, L. H., Sumaya, C. V., Grument, F. C., et al, 1985, Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency, N Engl. Med. 312:1151–1159.

    Article  CAS  Google Scholar 

  26. Hickey, D., Nalesnik, M., and Vivas, C., 1990, Renal retransplantation in patients who lost their allografts during management of previous posttransplant lymphoproliferative disease. Clin. Transpl. 4:187.

    Google Scholar 

  27. Shapiro, R. S., McClain, K., Frizzera, G., Gajl-Peczalska, K. J., Kersey, J. H., Blazar, B. R., Arthur, D. C., Patton, D. F., Greenberg, J. S., Burke, B. et al., 1988, Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation, Blood 71:1234–1243.

    PubMed  CAS  Google Scholar 

  28. Zutter, M. M., Marin, P. J., Sale, G. E., Shulman, H. M., Fisher, L., Thomas, E. D., and Durnam, D. M., 1988, Epstein-Barr virus lymphoproliferation after bone marrow transplantation, Blood 72:520–529.

    PubMed  CAS  Google Scholar 

  29. Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al., 1994, Infusions of donor leukocytes to treat Epstein-Barrvirus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation [see comments], N Engl.ℑ. Med. 330:1185–1191.

    CAS  Google Scholar 

  30. Lucas, K. G., Small, T. N., Heller, G., Dupoint, B., and O’Reilly, R. J., 1996, The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation, Blood 87:2594–2603.

    PubMed  CAS  Google Scholar 

  31. Wilson, J. B., Bell, J. L., and Levine, A. J., 1996, Expression of Epstein-Barr virus nuclear antigen-I induces B cell neoplasis in transgenic mice, EMBOℑ. 15:3117–3126.

    CAS  Google Scholar 

  32. Klein, G., 1989, Multiple phenotypic consequences of the Ig/Myc translocation in B cell-derived tumors [Review], Genes, & Chromosomes Cancer 1:3–8.

    CAS  Google Scholar 

  33. Magrath, I., 1990, The pathogenesis of Burkitt’s lymphoma [Review], Adv. Cancer Res. 55:133–270.

    PubMed  CAS  Google Scholar 

  34. Nilsson, K., and Ponten, J., 1975, Classification and biological nature of established human hematopoietic cell lines [Review], Int.ℑ. Cancer 15:321–341.

    CAS  Google Scholar 

  35. Gregory, C., 1992, Epstein-Barrvirus and B cell survival, Med. Virol. 2:205–220.

    Article  Google Scholar 

  36. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., and Rickinson, A. B., 1987, Differences in B cell growth phenotype reflect novel patterns of Epstein-Barrvirus latent gene expression in Burkitt’s lymphoma cells EMBROℑ. 6:2743–2751.

    CAS  Google Scholar 

  37. Woisetschlaeger, M., Strominger, J. L., and Speck, S. H., 1989, Mutually exclusive use ofviral promoters in Epstein-Barr virus latently infected lymphocytes, Proc. Natl. Acad. Sci. USA 86:6498–6502.

    PubMed  CAS  Google Scholar 

  38. Schafer, B. C., Strominger, J. L., and Speck, S. H., 1995, Redefining the Epstein-Barrvirus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines, Proc. Natl. Acad. Sci. USA 92:10565–10569.

    Google Scholar 

  39. Hu, L.-F., Chen, F., Altiok, E., Winberg, G., Klein, G., and Ernberg, I., 1996, Cell phenotype dependent alternative splicing of EBNA mRNAs in EBV-carrying cells, ℑ. Gen. Virol., in press.

    Google Scholar 

  40. Masucci, M. G., Contreras-Salazar, B., Ragnar, E., Falk, K., Minarovits, J., Ernberg, L., and Klein, G., 1989, 5-Azacytidine up regulates the expression of Epstein-Barrvirus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt’s lymphoma line rael. ℑ. Virol. 63:3135–3141.

    CAS  Google Scholar 

  41. Hu, L. F., Minarovits, J., Cao, S. L., Contreras-Salazar, B., Rymo, L., Falk, K., Klein, G., and Ernberg, I., 1991, Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barrvirus BNLF-1 5′-flanking region, ℑ. Virol. 65:1558–1567.

    Google Scholar 

  42. Minarovits, J., Minarovits-Kormuta, S., Ehlin-Henriksson B., Falk, K., Klein, G., and Ernberg, I., 1991, Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA, ℑ. Gen. Virol. 72:1591–1599.

    CAS  Google Scholar 

  43. Contreras-Brodin, B. A., Anvret, M., Imreh, S., Altiok, E., Klein, G., and Masucci, M. G., 1991, B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: Studies with somatic cell hybrids, ℑ Gen. Virol. 72:3025–3033.

    CAS  Google Scholar 

  44. Andersson, M. L., Stam, N. J., Klein, G., Ploegh, H. L., and Masucci, M. G., 1991, Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells, Int.ℑ. Cancer 47:544–550.

    CAS  Google Scholar 

  45. Burkitt, D. P., 1969, Etiology of Burkitt’s lymphoma—analternative hypothesis to a vectored virus Review], ℑ. Natl. Cancer Inst. 42:19–28.

    CAS  Google Scholar 

  46. Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palimiter, R. D., and Brinster, R. L., 1985, The c-myc oncogene driven by immunoglobulin enhancers induces lymphiod malignancy in transgenic mice, Nature 318:533–538.

    Article  PubMed  CAS  Google Scholar 

  47. Muller, J. R., Janz, S., Goedert, J. J., Potter, M., and Rabkin, C. S., 1995, Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men, Proc. Natl. Acad. Sci. USA 92:6577–6581.

    PubMed  CAS  Google Scholar 

  48. Axelson, H., Henriksson, M., Wang, Y., Magnusson, K. P., and Klein, G., 1995, The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt’s lymphoma lines but not in mouse plasmacytomas and rat immunocytomas, Eur.ℑ. Cancer 31A:2099–2104.

    CAS  Google Scholar 

  49. Henriksson, M., Bakardjiev, A., Klein, G., and Luscher, B., 1993, Phosphorylation sites map** in the N-terminal domain of c-myc modulate its transforming potential, Oncogene 8:3199–3209.

    PubMed  CAS  Google Scholar 

  50. Farrell, P. J., Allan G. J., Shanahan, F., Vousden, K. H., and Crook, T., 1991, p53 is frequently mutated in Burkitt’s lymphoma cell lines, EMBOℑ. 10:2879–2887.

    CAS  Google Scholar 

  51. Gaidano, G., and Dalla-Favera, R., 1996, Molecular biology of lymphoid neoplasms, in The Molecular Basis of Cancer, (J. Mendelsohn, P. Howley, M. Israel, and L. Liotta, eds.), in press, W.B. Saunders, Philadelphia.

    Google Scholar 

  52. Wiman, K. G., Magnusson, K. P., Ramqvist, T., and Klein, G., 1991, Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240, Oncogene 6:1633–1639.

    PubMed  CAS  Google Scholar 

  53. Burkitt, D. P., and Kyalwazi, S. K., 1967, Spontaneous remission of African lymphoma, Br.ℑ. Cancer 21:14–16.

    CAS  Google Scholar 

  54. Rooney, C. M., Edwards, C. F., Lenoir, G. M., Rupani, H., and Rickinson, A. B., 1986, Differential activation of cytotoxic responses by Burkitt’s lymphoma (BL)-cell lines: Relationship to the BL-cell surface phenotype. Cell. Immunol. 102:99–112.

    Article  PubMed  CAS  Google Scholar 

  55. de Campos-Lima, P. O., Torsteinsdottir, S., Cuomo, L. Klein, G., Sulitzeanu, D., and Masucci, M. G., 1993, Antigen processing and presentation by EBV-carrying cell lines: Cell-phenotype dependence and influence of the EBV-encoded LMP1, Int. ℑ. Cancer 53:856–862.

    Google Scholar 

  56. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Croom-Carter, D., Lee, S., Burrows, S. R., and et al., 1995, Restoration of endogenous antigen processing in Burkitt’s lymphoma cells by Epstein-Barrvirus latent membrane protein-I: Coordinate up-regulation of peptide transporters and HL4-class I antigen expression, Eur. ℑ. Immunol. 25:1374–1384.

    CAS  Google Scholar 

  57. Avila-Carino, J., Torsteinsdottir, S., Ehlin-Henriksson, B., Lenoir, G., Klein, G., Klein, E., and Masucci, M. G., 1987, Paired Epstein_Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: Stimulatory capacity in allogeneic mixed lymphocyte cultures, Int. ℑ. Cancer 40:691–97.

    CAS  Google Scholar 

  58. Gregory, C. D., Murray, R. J., Edwards, C. F., and Rickinson, A. B., 1988, Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barrvirus-positive Burkitt’s lymphoma underlies tumor cell escape from virus-specific T cell surveillance, ℑ. Exp. Med. 167: 1811–1824.

    CAS  Google Scholar 

  59. Masucci, M. G., Torsteindottir, S., Colombani, J., Brautbar, C., Klein, E., and Klein, G., 1987, Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines, Proc. Natl. Acad. Sci. USA 84:4567–4571.

    PubMed  CAS  Google Scholar 

  60. Beral, V., Peterman, T., Berkelman, R., and Jaffe, H., 1991, AIDS-associated non-Hodgkin lymphoma [see comments], Lancet 337:805–809.

    Article  PubMed  CAS  Google Scholar 

  61. Ballerini, P., Gaidano, G., Gong., J. Z., Tassi, V., Saglio, G., Knowles, D. M., and Dalla-Favera, R., 1993, Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma, Blood 81:166–176.

    PubMed  CAS  Google Scholar 

  62. Pelicci, P. G., Knowles, D. M., Arlin, Z. A., Wieczorek, R., Luciw, P., Dina, D., Basilico, C., and Dalla-Favera, R., 1986, Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis, ℑ. Exp. Med. 164:2049–2060.

    CAS  Google Scholar 

  63. Shibata, D., Weiss, L. M., Nathwani, B. N., Brynes, R. K., and Levine, A. M., 1991, Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin’s lymphoms, Blood 77:1527–1533.

    PubMed  CAS  Google Scholar 

  64. Neri, A., Barriga, F., Inghirami, G., Knowles, D. M., Neequaye, J., Magrath, I. T., and Dalla-Favera, R., 1991, Epstein-Barr virus infection precedes clonal expansion in Burkitt’s and acquired immunodefiency syndrome-associated lymphoam [see comments], Blood 77: 1092–1092.

    PubMed  CAS  Google Scholar 

  65. Karp, J. E., and Border, S., 1991, Acquired immunodeficiency syndrome and non-Hodgkin’s lymphomas [Review], Cancer Res. 51:4743–4756.

    PubMed  CAS  Google Scholar 

  66. MacMahon, E. M., Glass, J. D., Hayward, S. D., Mann, R. B., Becker, P. S., Charache, P., McArthur, J. C., and Ambinder, R. F., 1991, Epstein-Barr virus in AIDS-related primary central nervous system lymphoma, Lancet 338:969–973.

    Article  PubMed  CAS  Google Scholar 

  67. Giovanella, B., Nilsson, K., Zech, L., Yim, O., Klein, G., and Stehlin, J. S., 1979, Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions, Int. J Cancer 24:103–113.

    PubMed  CAS  Google Scholar 

  68. Nilsson, K., Gionvaella, B. C., Stehlin, J. S., and Klein, G., 1977, Tumorigenicity of human hematopoietic cell lines in athymic nude mice, Int. ℑ. Cancer 19:337–344.

    CAS  Google Scholar 

  69. Hamilton-Dutiot, S. J., Raphael, M., Audouin, J., Diebold, J., Lisse, I., Pedersen, C., Oksenhendler, E., Marelle, L., and Pallesen, G., 1993, In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site, Blood 82:619–624.

    Google Scholar 

  70. Pedersen, C., Gerstoft, J., Lundgren, J. D., Skinhoj, P., Bottzauw, J., Geisler, C., Hamilton-Dutiot, S. J., Thorsen, S., Lisse, I., Ralfkiaer, E., et al., 1991, HIV-associated lymphoma: Histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features, Eur. ℑ. Cancer 27:1416–1423.

    CAS  Google Scholar 

  71. Hamilton-Dutoit, S. J., Rea, D., Rapheal, M., Sandvej, K., Delecluse, H. J., Gisselbrecht, C., Marelle, L., van Krieken, H. J., and Pallesen, G., 1993, Epstein-Barrvirus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency, Am. ℑ. Pathol. 143:1072–1085.

    CAS  Google Scholar 

  72. Geddes, J. F., Bhattacharjee, M. B., Savage, K., Scaravilli, F., and McLaughlin, J. E., 1992, Primary cerebral lymphoma: A study of 47 cases probed for Epstein-Barrvirus genome, ℑ. Clin. Pathol. 45:587–590.

    CAS  Google Scholar 

  73. Hamilton-Dutoit, S. J., and Pallesen, G., 1992, A survey of Epstein-Barrvirus gene expression in sporadic non-Hodgkin’s lymphomas. Detection of Epstein-Barrvirus in a subset of peripheral T-cell lymphomas, Am. Pathol. 140: 1315–1325.

    CAS  Google Scholar 

  74. Young, L. S., Finerty, S., Brooks, L., Scullion, F., Rickinson, A. B., and Morgan, A. J., 1989, Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins, ℑ. Virol. 63: 1967–1974.

    CAS  Google Scholar 

  75. Rowe, M., Young, L. S., Crocker, J., Stokes, H., Henderson, S., and Rickinson, A. B., 1991, Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man, ℑ. Exp. Med. 173: 147–158.

    CAS  Google Scholar 

  76. Klein, G., 1973, The Epstein-Barrvirus, in The Herpesviruses (A. Kaplan, ed.), Academic Press, New York, pp. 521–555.

    Google Scholar 

  77. Herbst, H., Steinbrecher, E., Niedobitek, G., Young, L. S., Brooks, L., Muller-Lantzsch, N., and Stein, H., 1992, Distribution and phenotype of Epstein-Barrvirus-harboring cells in Hodgkin’s disease, Blood 80:484–491.

    PubMed  CAS  Google Scholar 

  78. Johansson, B., Klein, G., Henle, W., and Henle, G., 1970, Epstein-Barrvirus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin’s disease, Int. ℑ. Cancer 6:50–64.

    Google Scholar 

  79. Brousset, P., Chittal, S., Schlaifer, D., Icart, J., Payen, C., Rigal-Huguet, F., Voigt, J. J., and Delsol, G., 1991, Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin’s disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections [see comments], Blood 77:1781–1786.

    PubMed  CAS  Google Scholar 

  80. Coates, P. J., Slavin, G., and D’Ardenne, AJ., 1991, Persistence of Epstein-Barrvirus in Reed-Sternberg cells throughout the course of Hodgkin’s disease, ℑ. Pathol. 164:91–297.

    Google Scholar 

  81. Guarner, J., del Rio, C., Hendrix, L., and Unger, E. R., 1990, Composite Hodgkin’s and non-Hodgkin’s lymphoma in a patient with acquired immune deficiency syndrome. In situ demonstration of Epstein-Barr virus, Cancer 66:796–800.

    PubMed  CAS  Google Scholar 

  82. Herbst, H., Niedobitek, G., Kneba, M., Hummel, M., Finn, T., Anagnostopoulos, I., Bergholz, M., Krieger, G., and Stein, H., 1990, High incidence of Epstein-Barr virus genomes in Hodgkin’s disease, Am. J. Pathol. 137:13–18.

    PubMed  CAS  Google Scholar 

  83. Neidobitek, G., Deacon, E. M., Young, L. S., Herbst, H., Hamilton-Dutoit, S. J., and Pallesen, G., 1991, Epstein-Barr virus gene expression in Hodgkin’s disease letter; comment], Blood 78:1628–1630.

    Google Scholar 

  84. Uccini, S., Morardo, F., Stoppacciaro, A., Gradilone, A., Agliano, A. M., Faggioni, A., Manzari, V., Vago, L., Costanzi, G., Ruco, L. P., et al., 1990, High frequency of Epstein-Barr virus genome detection in Hodgkin’s disease of HIV-positive patients, Int. ℑ. Cancer 46:581–585.

    CAS  Google Scholar 

  85. Uhara, H., Sato, Y., Mukai, K., Akao, I., Matsuno, Y., Furuya, S., Hoshikawa, T., Shimosato, Y., and Saida, T., 1990, Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin’s disease using the polymerase chain reaction and in situ hybridization, Jpn. J Cancer Res. 81:272–278.

    PubMed  CAS  Google Scholar 

  86. Weiss, L. M., Movahed, L. A., Warnke, R. A., and Sklar, J., 1989, Detection of Epstein-Barr viral genomes in Reed-Stembergcells of Hodgkin’s disease, N. Engl. J Med. 320:502–506.

    PubMed  CAS  Google Scholar 

  87. Weiss, L. M., Strickler, J. G., Warnke, R. A., Purtilo, D. T., and Sklar, J., 1987, Epstein-Barr viral DNA in tissues of Hodgkin’s disease, Am. J Pathol. 129:86–91.

    PubMed  CAS  Google Scholar 

  88. Anagnostopoulos, I., Hummel, M., Finn, T., Tiemann, M., Korbjuhn, P., Dimmler, C., Gatter, K., Dallenbach, F., Parwaresch, M. R., and Stein, H., 1992, Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type, Blood 801:804–1812.

    Google Scholar 

  89. Boiocchi, M., Carbone, A., De Re, V.,and Dolcetti, R., 1989, Is the Epstein-Barr virus involved in Hodgkin’s disease?, Tumori 75:345–350.

    PubMed  CAS  Google Scholar 

  90. Gledhill, S., Gallagher, A., Jones, D. B., Krajewski, A. S., Alexander, F. E., Klee, E., Wright, D. H., O’Brien, C., Onions, D. E., and Jarrett, R. F., 1991, Viral involvement in Hodgkin’s disease: Detection of clonal type A Epstein-Barr virus genomes in tumour samples, Br. J. Cancer 64:227–232.

    PubMed  CAS  Google Scholar 

  91. Jarrett, R. F., Gallagher, A., Jones, D. B., Alexander, F. E., Krajewski, A. S., Kelsey, A., Adams, J., Angus, B., Gledhill, S., Wright, D. H. et al., 1991, Detection of Epstein-Barr virus genomes in Hodgkin’s disease: relation to age [see comments], 3. Clin. Pathol. 44:844–848.

    CAS  Google Scholar 

  92. Staal, S. P., Ambinder, R., Beschorner, W. E., Hayward, G. S., and Mann, R., 1989, A survey of Epstein-Barrvirus DNA in lymphoid tissue. Frequent detection in Hodgkin’s disease [see comments], Am. J. Clin. Pathol. 91:1–5.

    PubMed  CAS  Google Scholar 

  93. Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M., and Young, L. S., 1991, Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin’s disease [see comments], Lancet 337:320–322.

    Article  PubMed  CAS  Google Scholar 

  94. Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., and Young, L. S., 1993, Epstein-Barr virus and Hodgkin’s disease: Transcriptional analysis of virus latency in the malignant cells, J. Exp. Med. 177:339–349.

    Article  PubMed  CAS  Google Scholar 

  95. Delsol, G., Brousset, P., Chittal, S., and Rigal-Huguet, F., 1992, Correlation of the expression of Epstein-Barrvirus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin’s disease, Am. J. Pathol. 140:247–253.

    PubMed  CAS  Google Scholar 

  96. Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Muller-Lantzsch, N., and Stein, H., 1991, Epstein-Barrvirus latent membrane protein expression in Hodgkin and Reed-Sternberg cells, Proc. Natl. Acad. Sci. USA 88:4766–4770.

    PubMed  CAS  Google Scholar 

  97. Poppema, S., van Imhoff, G., Torensma, R., and Smit, J., 1985, Lymphadenopathy morphologically consistent with Hodgkin’s disease associated with Epstein-Barr virus infection, Am.J. Clin. Pathol. 84:385–390.

    PubMed  CAS  Google Scholar 

  98. Zhou, X. G., Hamilton-Dutoit, S. J., Yan, Q. H., and Pallesen, G., 1993, The association between Epstein-BarrVirus and Chinese Hodgkin’s disease, Int. J. Cancer 55:359–363.

    PubMed  CAS  Google Scholar 

  99. Libetta, C. M., Pringle, J. H., Angel, C. A., Craft, A. W., Malcolm, A. J., and Lauder, I., 1990, Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin’s disease [see comments], J. Pathol. 161:255–260.

    Article  PubMed  CAS  Google Scholar 

  100. Vestlev, P. M., Pallesen, G., Sandvej, K., Hamilton-Dutoit, S. J., and Bendtzen, S. M., 1992, Prognosis of Hodgkin’s disease is not influenced by Epstein-Barr virus latent membrane protein Fetter], Int. J. Cancer 50:670–671.

    PubMed  CAS  Google Scholar 

  101. Weinreb, M., Day, P. J., Murray, P. G., Raafat, F., Crocker, J., Parkes, S. E., Coad, N. A., Jones, J. T., and Mann, J. R., 1992, Epstein-Barr virus (EBV) and Hodgkin’s disease in children: Incidence of EBV latent membrane protein in malignant cells, ℑ. Pathol. 168:365–369.

    CAS  Google Scholar 

  102. Munoz, N., Davidson, R. J., Witthoff, B., Ericsson, J. E., and De-The, G., 1978, Infectious mononucleosis and Hodgkin’s disease, Int.J. Cancer 22:10–13.

    PubMed  CAS  Google Scholar 

  103. Rosdahl, N., Larsen, S. O., and Clemmesen, J.,1974, Hodgkin’s disease in patients with previous infectious mononucleosis: 30 years’ experience, Br. Med. J. 2:253–256.

    Google Scholar 

  104. Knecht, H., Bachmann, E., Brousset, P., Sandvej, K., Nadal, D., Bachmann, F., Odermatt, B. F., Delsol, G., and Pallesen, G., 1993, Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin’s disease and identical to those observed in nasopharyngeal carcinoma, Blood 82:2937–2942.

    PubMed  CAS  Google Scholar 

  105. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, R. R., Sciotto, C. G., Wahl, R., Sands, J,, Gottman, D., Katz, B. Z., and Sklar, J., 1988, T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections, N Engl. ℑ. Med. 318:733–741.

    CAS  Google Scholar 

  106. Chan, J. K., Ng, C. S., Lau, W. H., and Lo, S. T., 1987, Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms, Am. J. Surg. Pathol. 11:418–429.

    PubMed  CAS  Google Scholar 

  107. Chott, A., Rappersberger, K., Schlossarek, W., and Radaszkiewicz, T., 1988, Peripheral T cell lymphoma presenting primarily as lethal midline granuloma, Hum. Pathol. 19:1093–1101.

    PubMed  CAS  Google Scholar 

  108. Hastrup, N., Hamilton-Dutoit, S. Ralfkiaer, E., and Pallesen, G., 1991, Peripheral T-cell lymphomas: An evaluation of reproducibility of the updated Kiel classification, Histopathology 18:99–105.

    PubMed  CAS  Google Scholar 

  109. Ohshima, K., Kikuchi, M., Eguchi, F., Masuda, Y., Sumiyoshi, Y., Mohtai, H., Takeshita, M., and Kimura, N., 1990, Analysis of Epstein-Barrviral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows Arch. B Cell Pathol. 59:383–390.

    CAS  Google Scholar 

  110. Ott, G., Ott, M. M., Feller, A. C., Seidl, S., and Muller-Hemelink, H. K., 1992, Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population, Int. ℑ. Cancer 51:562–567.

    CAS  Google Scholar 

  111. Su, I. J., Tsai, T. F., Cheng, A. L., and Chen, C. C., 1993, Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma, ℑ. Am. Acad. Dermatol. 29:685–692.

    CAS  Google Scholar 

  112. Minarovits, J., Hu, L. F., Imai, S., Harabuchi, Y., Kataura, A., Minarovits-Kormuta, S., Osato, T., and Klein, G., 1994, Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas, ℑ. Gen. Virol. 75:77–84.

    CAS  Google Scholar 

  113. Pallesen, G., Hamilton-Dutoit, S. J., and Zhou, X., 1993, The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin’s disease: Two new developments in the EBV field [Review], Adv. Cancer Res. 62:179–239.

    PubMed  CAS  Google Scholar 

  114. Ambinder, R. F., and Mann, R. B., 1994, Detection and characterization of Epstein-Barr virus in clinical specimens Review], Am. J. Pathol. 145:239–252.

    PubMed  CAS  Google Scholar 

  115. de Bruin, P. C., Jiwa, M., Oudejans, J. J., van der Valk, P., van Heerde, P., Sabourin, J. C., Csanaky, G., Gaulard, P., Noorduyn, A. L., Willemze, R. et al., 1994, Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site, Blood 83:1612–1618.

    PubMed  Google Scholar 

  116. Sato, E., Tokunaga, M., Hasui, K., Kitajima, S., and Nomoto, M., 1990, Pathoepidemiological features of adult T-cell lymphoma/leukemia in an endemic area: Kagoshima, Japan, Cancer Detection Prev. 14:423–429.

    CAS  Google Scholar 

  117. De Bruin, P. C., Jiwa, N. M., Van der Valk, P., Van Heerde, P., Gordijn, R., Ossenkoppele, G. J., Walboomers, J. M., and Meijer, C. J., 1993, Detection of Epstein-Barrvirus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein-1 positivity and clinical course, Histopathology 23:509–518.

    PubMed  Google Scholar 

  118. Kumar, S., Kumar, D., Kingma, D. W., and Jaffe, E. S., 1993, Epstein-Barrvirus-associated T-cell lymphoma in a renal transplant patient [see comments], Am. J. Surg. Pathol. 17:1046–1053.

    Article  PubMed  CAS  Google Scholar 

  119. Tien, H. F., Su, I. J., Chuang, S. M., Lee, F. Y., Liu, M. C., Tsai, T. F., Lin, K. H., and Chen, R. L., 1993, Cytogenetic characterization of Epstein-Barr virus-associated T-cell malignancies. Cancer Genet. Cytogenet. 69:25–30.

    Article  PubMed  CAS  Google Scholar 

  120. Mori, M., Kurozumi, H., Akagi, K., Tanaka, Y., Imai, S., and Osato, T., 1992, Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis letter], N. Engl. ℑ. Med. 327:58.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microbiology and Tumor Biology Center (MTC), Karolinska Institutet, S-17177, Stockholm, Sweden

    George Klein

Authors
  1. George Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Peter G. Medveczky  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Klein, G. (2002). EBV and B Cell Lymphomas. In: Medveczky, P.G., Friedman, H., Bendinelli, M. (eds) Herpesviruses and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46808-5_7

Download citation

  • DOI: https://doi.org/10.1007/0-306-46808-5_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45890-3

  • Online ISBN: 978-0-306-46808-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation